What is stock price of Takeda Pharma in Japan?

What is stock price of Takeda Pharma in Japan?

Performance Outlook

Previous Close 3,616.00
Ask 3,672.00 x 0
Day’s Range 3,623.00 – 3,681.00
52 Week Range 2,993.00 – 3,842.00
Volume 5,973,700

Should I buy Takeda stock?

The consensus among Wall Street research analysts is that investors should “hold” Takeda Pharmaceutical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TAK, but not buy additional shares or sell existing shares.

Why did Takeda stock drop?

Shares of Japanese pharmaceutical company Takeda Pharmaceutical (TAK 1.25%) were down by more than 10% as Wednesday’s closing bell neared, following the company’s decision to prematurely stop a key drug trial due to safety concerns.

Does Takeda pay a dividend?

When does Takeda Pharmaceutical pay dividends? Takeda Pharmaceutical pays a dividend 2 times a year.

Where is Christophe Weber from?

In a recent interview with Nikkei, Weber talked about how his early career shaped him as a business person. I was born and raised in France and studied pharmacy at university under the influence of my parents, who are both doctors.

Is Takeda Pharmaceutical a buy?

The 14 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 15.96, with a high estimate of 25.37 and a low estimate of 13.05. The median estimate represents a +6.55% increase from the last price of 14.98.

Is Takeda a buy Zacks?

See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank….Momentum Scorecard. More Info.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.08%
2 Buy 18.56%
3 Hold 10.15%
4 Sell 5.79%

How much debt does Takeda have?

Compare TAK With Other Stocks

Takeda Pharmaceutical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder’s Equity
2020-03-31 $74.46B $43.49B
2019-12-31 $75.03B $44.86B
2019-09-30 $74.50B $45.29B

Is Takeda a big pharma?

Takeda is one of the ten largest pharmaceutical companies in the world and the largest in Asia. Following its $62 billion acquisition, in 2019, of the biopharmaceutical company Shire, based in Ireland—a deal Weber championed—Takeda had a larger footprint than ever before; it now has operations in some 80 countries.

Is Takeda a private company?

The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology….Takeda Pharmaceutical Company.

Global headquarters in Nihonbashi
Type Public KK
Traded as TYO: 4502 NAG: 4502 FSE: 4502 NYSE: TAK Nikkei 225 component (TYO) TOPIX Core30 component (TYO)